Skip to content
Open Data Finder
Open Government Canada

Summary Safety Review - MELATONIN (N-acetyl-5-methoxytryptamine) - Review of the Safety of Melatonin in Children and Adolescents

Published by Health Canada | Santé Canada

About this dataset

After becoming aware of international reports about neurological side effects, such as anxiety, panic reaction, visual hallucinations and seizures, possibly associated with melatonin use in children and adolescents ranging from newborn to 18 years old (pediatric population), Health Canada did a review of this safety issue in this age group.

Summary Safety Review - MELATONIN (N-acetyl-5-methoxytryptamine) - Review of the Safety… · Open Data Finder